WAY-600 is primarily used in scientific research as a potent and selective inhibitor of mTOR (mammalian target of rapamycin), a key protein kinase involved in cell growth, proliferation, and survival. Its ability to specifically target the mTOR pathway makes it a valuable tool in studies related to cancer, neurodegeneration, and metabolic disorders. Researchers utilize WAY-600 to probe signaling pathways in cellular and animal models, helping to elucidate the role of mTOR in disease mechanisms. Due to its inhibitory action, it has shown potential in preclinical studies for suppressing tumor growth and enhancing the effects of other anticancer agents. However, it remains strictly for experimental use and is not approved for therapeutic applications in humans.